Source: Annual Congress 2009 - COPD: basic science and clinical studies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Armstrong, C. Sargent, D. Singh (Manchester, Loughborough, United Kingdom). Glucocorticoid sensitivity of LPS stimulated COPD alveolar macrophages. Eur Respir J 2009; 34: Suppl. 53, 913

Member's Comments

No comment yet.

Related content which might interest you: Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD Source: Annual Congress 2011 - Experimental modulation of airway inflammation Year: 2011 Increased SDF-1alpha production from alveolar macrophages in sarcoidosis in vitro Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008 Inhibition of cytokine release from alveolar macrophages in sarcoidosis by pentoxifylline: comparison with dexamethasone Source: Eur Respir J 2001; 18: Suppl. 33, 195s Year: 2001 IFNγ induces steroid unresponsiveness in smokers alveolar macrophages Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Expression of surface receptors on alveolar macrophages and monocytes from patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 453s Year: 2004 Cytokine production of alveolar macrophages is decreased by OR2AT4 Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Antiinflammatory effects of formoterol in macrophages as a model for alveolar macrophages in COPD Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Differential response of monocyte-derived macrophages from COPD and healthy subjects to LPS/IFN? stimulation Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages Source: Eur Respir J 2006; 28: 486-495 Year: 2006 Reduced haemeoxygenase-1 immunoreactivity in alveolar macrophages in severe COPD Source: Eur Respir J 2001; 18: Suppl. 33, 75s Year: 2001 Resveratrol impairs cytokine release from human airway smooth muscle cells (HASMCs) and alveolar macrophages (AM) in COPD Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Glucocorticoids induce a shift in chemokine profile in LPS-stimulated human alveolar macrophages Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 Pattern recognition receptor expression and LPS binding capacity of human monocytes and alveolar macrophages Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 No evidence of corticosteroid resistance in COPD alveolar macrophages Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Increased in vitro production of IP-10/CXCL10 and MIG/CXCL9 by alveolar macrophages in sarcoidosis and EAA but not in IPF Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Phenotype polarization of alveolar macrophages in COPD patients Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics Year: 2010 Increased production of caspase-1 by alveolar macrophages in patients with pulmonary sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 585s Year: 2002 Fluticasone increases in vitro efferocytosis by human alveolar macrophages Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Human neutrophil peptides stimulate the production of TNF alpha by alveolar macrophages from patients with sarcoidosis Source: Annual Congress 2007 - Inflammatory cell biology Year: 2007 Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages in vitro Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research Year: 2005